Lipid Emulsion Inhibits Vasodilation Induced by a Toxic Dose of Bupivacaine via Attenuated Dephosphorylation of Myosin Phosphatase Target Subunit 1 in Isolated Rat Aorta

Lipid emulsions are widely used for the treatment of systemic toxicity that arises from local anesthetics. The goal of this in vitro study was to examine the cellular mechanism associated with the lipid emulsion-mediated attenuation of vasodilation induced by a toxic dose of bupivacaine in isolated endothelium-denuded rat aorta. The effects of lipid emulsion on vasodilation induced by bupivacaine, mepivacaine, and verapamil were assessed in isolated aorta precontracted with phenylephrine, the Rho kinase stimulant NaF, and the protein kinase C activator phorbol 12,13-dibutyrate (PDBu). The effects of Rho kinase inhibitor Y-27632 on contraction induced by phenylephrine or NaF were assessed. The effects of bupivacaine on intracellular calcium concentrations ([Ca2+]i) and tension induced by NaF were simultaneously measured. The effects of bupivacaine alone and lipid emulsion plus bupivacaine on myosin phosphatase target subunit 1 (MYPT1) phosphorylation induced by NaF were examined in rat aortic vascular smooth muscle cells. In precontracted aorta, the lipid emulsion attenuated bupivacaine-induced vasodilation but had no effect on mepivacaine-induced vasodilation. Y-27632 attenuated contraction induced by either phenylephrine or NaF. The lipid emulsion attenuated verapamil-induced vasodilation. Compared with phenylephrine-induced precontracted aorta, bupivacaine-induced vasodilation was slightly attenuated in NaF-induced precontracted aorta. The magnitude of the bupivacaine-induced vasodilation was higher than that of a bupivacaine-induced decrease in [Ca2+]i. Bupivacaine attenuated NaF-induced MYPT1 phosphorylation, whereas lipid emulsion pretreatment attenuated the bupivacaine-induced inhibition of MYPT1 phosphorylation induced by NaF. Taken together, these results suggest that lipid emulsions attenuate bupivacaine-induced vasodilation via the attenuation of inhibition of MYPT1 phosphorylation evoked by NaF.

[1]  Belinda S. Akpa,et al.  Multi-modal contributions to detoxification of acute pharmacotoxicity by a triglyceride micro-emulsion. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Jung-Chul Park,et al.  Bupivacaine-induced Vasodilation Is Mediated by Decreased Calcium Sensitization in Isolated Endothelium-denuded Rat Aortas Precontracted with Phenylephrine , 2014, The Korean journal of pain.

[3]  B. Graf,et al.  Lipid emulsion pretreatment has different effects on mepivacaine and bupivacaine cardiac toxicity in an isolated rat heart model. , 2014, British journal of anaesthesia.

[4]  Young-Sool Hah,et al.  Systemic Blockage of Nitric Oxide Synthase by L-NAME Increases Left Ventricular Systolic Pressure, Which Is Not Augmented Further by Intralipid® , 2014, International journal of biological sciences.

[5]  B. Graf,et al.  Lipid Rescue Reverses the Bupivacaine-induced Block of the Fast Na+ Current (INa) in Cardiomyocytes of the Rat Left Ventricle , 2014, Anesthesiology.

[6]  S. Ok,et al.  Lipid Emulsions Enhance the Norepinephrine-Mediated Reversal of Local Anesthetic-Induced Vasodilation at Toxic Doses , 2013, Yonsei medical journal.

[7]  Seong Min Yang,et al.  Effect of Two Lipid Emulsions on Reversing High-Dose Levobupivacaine-Induced Reduced Vasoconstriction in the Rat Aortas , 2013, Cardiovascular Toxicology.

[8]  Jeong Yeol Han,et al.  Lipid emulsion-mediated reversal of toxic-dose aminoamide local anesthetic-induced vasodilation in isolated rat aorta , 2013, Korean journal of anesthesiology.

[9]  M. Eghbali,et al.  Fatty-acid oxidation and calcium homeostasis are involved in the rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats* , 2012, Critical care medicine.

[10]  G. Weinberg Lipid Emulsion Infusion: Resuscitation for Local Anesthetic and Other Drug Overdose , 2012, Anesthesiology.

[11]  Jeong Yeol Han,et al.  Vasoconstriction Potency Induced by Aminoamide Local Anesthetics Correlates with Lipid Solubility , 2012, Journal of biomedicine & biotechnology.

[12]  Seong-chun Kwon,et al.  Protein kinases participate in the contraction in response to levobupivacaine in the rat aorta. , 2012, European journal of pharmacology.

[13]  E. Hwang,et al.  Levobupivacaine-induced contraction of isolated rat aorta is calcium dependent. , 2011, Canadian journal of physiology and pharmacology.

[14]  Chang-Shin Park,et al.  Lipid Emulsion Reverses Levobupivacaine-induced Responses in Isolated Rat Aortic Vessels , 2011, Anesthesiology.

[15]  G. Weinberg,et al.  Update on the use of Lipid Emulsions in Local Anesthetic Systemic Toxicity: A Focus on Differential Efficacy and Lipid Emulsion as Part of Advanced Cardiac Life Support , 2011, International anesthesiology clinics.

[16]  E. Hwang,et al.  The Direct Effect of Levobupivacaine in Isolated Rat Aorta Involves Lipoxygenase Pathway Activation and Endothelial Nitric Oxide Release , 2010, Anesthesia and analgesia.

[17]  B. Graf,et al.  Lipid Emulsion Improves Recovery from Bupivacaine-Induced Cardiac Arrest, but Not from Ropivacaine- or Mepivacaine-Induced Cardiac Arrest , 2009, Anesthesia and analgesia.

[18]  T. Akata Cellular and molecular mechanisms regulating vascular tone. Part 2: regulatory mechanisms modulating Ca2+ mobilization and/or myofilament Ca2+ sensitivity in vascular smooth muscle cells , 2007, Journal of Anesthesia.

[19]  S. Chae,et al.  A role for Rho kinase in vascular contraction evoked by sodium fluoride. , 2006, Biochemical and biophysical research communications.

[20]  A. Santos,et al.  Systemic Toxicity of Levobupivacaine, Bupivacaine, and Ropivacaine during Continuous Intravenous Infusion to Nonpregnant and Pregnant Ewes , 2001, Anesthesiology.

[21]  Michael J. Mulvany,et al.  Location of Resistance Arteries , 2001, Journal of Vascular Research.

[22]  D. Hartshorne,et al.  Inhibitory Phosphorylation Site for Rho-associated Kinase on Smooth Muscle Myosin Phosphatase* , 1999, The Journal of Biological Chemistry.

[23]  R. Busse,et al.  Signal transduction in endothelium-dependent vasodilatation. , 1993, European heart journal.

[24]  B. Covino,et al.  Local Anesthetics , 1987, Handbook of Experimental Pharmacology.

[25]  N. Sperelakis,et al.  Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities. , 1984, Biochemical pharmacology.